Julien Chlasta
is the founder and CEO of BioMeca, a biotech company in Lyon, France, that
specializes in biophysical analysis of biological systems. He completed his
Ph.D. in Cellular Biology at Université Claude Bernard Lyon 1 in 2016, focusing
on the role of the basement membrane in epithelial morphogenesis in Drosophila
melanogaster. Since co-founding BioMeca in 2017, Julien has driven the
development of advanced biophysical measurement techniques, particularly for
skin and hair analysis, gaining recognition from the cosmetics and
pharmaceutical sectors. His research interests include extracellular matrix
mechanics, epithelial morphogenesis, and biophysical tool development for
biomedical use.
Julien Chlasta
is the founder and CEO of BioMeca, a biotech company in Lyon, France, that
specializes in biophysical analysis of biological systems. He completed his
Ph.D. in Cellular Biology at Université Claude Bernard Lyon 1 in 2016, focusing
on the role of the basement membrane in epithelial morphogenesis in Drosophila
melanogaster. Since co-founding BioMeca in 2017, Julien has driven the
development of advanced biophysical measurement techniques, particularly for
skin and hair analysis, gaining recognition from the cosmetics and
pharmaceutical sectors. His research interests include extracellular matrix
mechanics, epithelial morphogenesis, and biophysical tool development for
biomedical use.